Medicamenta

Medicamenta (Medicamenta Ecuatoriana S.A.) is a leading pharmaceutical company in Ecuador and a core subsidiary of the Adium Pharma group, a major Latin American pharmaceutical conglomerate. The company specializes in the development, manufacturing, and commercialization of high-complexity therapies, serving as a strategic regional partner for global biotechnology leaders such as BioMarin, Seagen, Roche, and Moderna. Medicamenta's portfolio is heavily focused on oncology, hematology, and rare diseases, providing innovative treatments like antibody-drug conjugates and enzyme replacement therapies to the Ecuadorian market. With over 35 years of experience, the company operates state-of-the-art distribution and manufacturing facilities and maintains a dominant position in both the private and institutional healthcare sectors. As part of the Adium group, it also facilitates the regional distribution of advanced biologics and vaccines, including Moderna's COVID-19 vaccine.